Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis

Journal of Experimental Medicine

Volumn 194, Issue 7, 2001, Pages 873-881

  McQualter, J L ^a   Darwiche, R ^a   Ewing, C ^a   Onuki, M ^a   Kay, T W ^a   Hamilton, J A ^a   Reid, H H ^a   Bernard, C C A ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEMYELINATION; DISEASE MODEL; ENCEPHALITIS; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; LEUKOCYTE MIGRATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNITY, NATURAL; IMMUNOTHERAPY; MICE; MICE, INBRED NOD; MICE, MUTANT STRAINS; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; T-LYMPHOCYTES;

EID: 0035476518     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.7.873     Document Type: Article

References (55)

1. Assessment of animal models for MS and demyelmating disease in the design of rational therapy
2. Minireview: Autoimmune responses to myelin proteolipid protein
3. Autoantigens in experimental autoimmune encephalomyelitis and multiple sclerosis
4. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
5. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: Characterization of immunodominant T- and B-cell epitopes
6. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
7. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein
8. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors
9. Brain dendritic cells and macrophages/microglia in central nervous system inflammation
10. Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: A possible role in rheumatoid arthritis
11. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells
12. Microglial phagocytosis is modulated by pro- and antiinflammatory cytokines
13. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-γ. Increased TNF-α but not IL-1 activity
14. Colony stimulating factors, cytokines and monocyte-macrophages-some controversies
15. Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor
16. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes
17. Rheumatoid arthritis: Opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs
18. Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice
19. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice
20. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice
21. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor
22. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage
23. Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity
24. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity
25. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
26. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs
27. T cell functions in granulocyte/macrophage colony--stimulating factor deficient mice
28. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55
29. Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?
30. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein
31. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis
32. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice
33. Multiple sclerosis: An autoimmune disease of multifactorial etiology
34. Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy
35. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins
36. Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor
37. Development of dendritic cells in culture from human and murine thymic precursor cells
38. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo
39. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis
40. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent
41. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice
42. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats
43. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis
44. Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes
45. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells
46. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-β1 (TGF-β1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia
47. Immune cell entry to the CNS-a focus for immunoregulation of EAE
48. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
49. Chemokine expression in murine experimental allergic encephalomyelitis
50. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
51. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-α inhibitor
52. Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells
53. Chemokines and disease
54. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1